PHI BIOMED
Seoul
About PHI BIOMED
PHI BIOMED offers the research and development of nanomedical and smart biomaterials products in contact lenses, serums, and proteins.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $6.9M
- Funding stage: Seed
- Last round: Seed (Aug 2019)
- Website: phibiomed.co.kr
- Phone: +82-705-220-1040
Industries & Categories
Biotechnology, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/phi-biomed-209661 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.